Meta-Analysis
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 348-361
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.348
Figure 1
Figure 1 PRISMA flow diagram.
Figure 2
Figure 2 Risk of the development of colorectal neoplasia in inflammatory bowel disease patients with post-inflammatory polyps. M-H: Mantel-Haenszel; CI: Confidence interval; PIPs: Post-inflammatory polyps.
Figure 3
Figure 3 Risk of the development of colorectal cancer in inflammatory bowel disease patients with post-inflammatory polyps. M-H: Mantel-Haenszel; CI: Confidence interval; PIPs: Post-inflammatory polyps.
Figure 4
Figure 4 Risk of the development of colorectal neoplasia in ulcerative colitis patients with post-inflammatory polyps. M-H: Mantel-Haenszel; CI: Confidence interval; PIPs: Post-inflammatory polyps.
Figure 5
Figure 5 Risk of the development of colorectal neoplasia in inflammatory bowel disease patients with post-inflammatory polyps in cohort, case-control and cross-sectional studies. M-H: Mantel-Haenszel; CI: Confidence interval; PIPs: Post-inflammatory polyps.
Figure 6
Figure 6 Funnel plots of the included studies.